高级检索
当前位置: 首页 > 详情页

Advanced strategies of covalent organic framework nanomedicines in targeting and overcoming biological barriers

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ 卓越:梯队期刊

机构: [1]Univ Elect Sci & Technol China, Dept Urol, Sichuan Clin Res Ctr Canc, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr,Affiliat, Chengdu 610041, Peoples R China [2]Univ Elect Sci & Technol China, Affiliated Canc Hosp, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Dept Emergency,Sichuan Cl, Chengdu 610041, Peoples R China [3]Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, State Key Lab Syst Med Canc,Dept Intervent Oncol, Shanghai 200025, Peoples R China
出处:
ISSN:

关键词: Covalent organic frameworks (COFS) Drug carrier Cancer therapy Biocompatibility Biological Barriers

摘要:
Covalent organic frameworks (COFs) are crystalline and porous materials formed from periodically organized organic molecules bonded covalently to create highly stable architectures. Their mechanical properties can be precisely adjusted through structural modifications, making COFs exceptionally suitable for applications in cancer treatment and drug delivery. This review summarizes strategies for controlling the mechanical properties of COFs, including adjustments in structural dimensions, pore sizes and host-guest interactions. The remarkable advancements in drug delivery, cancer therapy, photodynamic therapy and photothermal therapy achieved through COFs with tunable mechanical properties are then discussed. By providing deeper insights into the biomedical applications of COF systems, this review aims to foster interdisciplinary research combining nanomedicine and COF materials. Additionally, the review explores recent studies and discoveries on COFs' potential as innovative drug carriers capable of biological overcoming barriers such as the blood-brain barrier, nasal mucosa, cutaneous layers and oral mucosa. Greater insight into both the limitations and potential of COFs could pave the way for developing more effective and targeted strategies within this challenging field. (c) 2025 Published by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学
JCR分区:
出版当年[2024]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Univ Elect Sci & Technol China, Dept Urol, Sichuan Clin Res Ctr Canc, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr,Affiliat, Chengdu 610041, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号